AngioDynamics (ANGO) Reports Q1 Loss, Tops Revenue Estimates

AngioDynamics (ANGO) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of$ 0.14. This compares to a loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +28.57%. A quarter ago, it was expected that this medical device maker would post a loss of$ 0.13 per share when it actually produced a loss of $0.03, delivering a surprise of +76.92%.Over the last four quarters, the compan ...